These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 16990004)

  • 41. Non-nucleoside inhibitors of the hepatitis C virus NS5B RNA-dependant RNA polymerase: 2-aryl-3-heteroaryl-1,3-thiazolidin-4-one derivatives.
    Rawal RK; Katti SB; Kaushik-Basu N; Arora P; Pan Z
    Bioorg Med Chem Lett; 2008 Dec; 18(23):6110-4. PubMed ID: 18947995
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Identification of N,N-disubstituted phenylalanines as a novel class of inhibitors of hepatitis C NS5B polymerase.
    Chan L; Reddy TJ; Proulx M; Das SK; Pereira O; Wang W; Siddiqui A; Yannopoulos CG; Poisson C; Turcotte N; Drouin A; Alaoui-Ismaili MH; Bethell R; Hamel M; L'Heureux L; Bilimoria D; Nguyen-Ba N
    J Med Chem; 2003 Apr; 46(8):1283-5. PubMed ID: 12672227
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Design and synthesis of lactam-thiophene carboxylic acids as potent hepatitis C virus polymerase inhibitors.
    Barnes-Seeman D; Boiselle C; Capacci-Daniel C; Chopra R; Hoffmaster K; Jones CT; Kato M; Lin K; Ma S; Pan G; Shu L; Wang J; Whiteman L; Xu M; Zheng R; Fu J
    Bioorg Med Chem Lett; 2014 Aug; 24(16):3979-85. PubMed ID: 24986660
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Discovery of substituted N-phenylbenzenesulphonamides as a novel class of non-nucleoside hepatitis C virus polymerase inhibitors.
    May MM; Brohm D; Harrenga A; Marquardt T; Riedl B; Kreuter J; Zimmermann H; Ruebsamen-Schaeff H; Urban A
    Antiviral Res; 2012 Aug; 95(2):182-91. PubMed ID: 22580131
    [TBL] [Abstract][Full Text] [Related]  

  • 45. 2-(3-Thienyl)-5,6-dihydroxypyrimidine-4-carboxylic acids as inhibitors of HCV NS5B RdRp.
    Pacini B; Avolio S; Ercolani C; Koch U; Migliaccio G; Narjes F; Pacini L; Tomei L; Harper S
    Bioorg Med Chem Lett; 2009 Nov; 19(21):6245-9. PubMed ID: 19800789
    [TBL] [Abstract][Full Text] [Related]  

  • 46. 5,5'- and 6,6'-dialkyl-5,6-dihydro-1H-pyridin-2-ones as potent inhibitors of HCV NS5B polymerase.
    Ellis DA; Blazel JK; Tran CV; Ruebsam F; Murphy DE; Li LS; Zhao J; Zhou Y; McGuire HM; Xiang AX; Webber SE; Zhao Q; Han Q; Kissinger CR; Lardy M; Gobbi A; Showalter RE; Shah AM; Tsan M; Patel RA; LeBrun LA; Kamran R; Bartkowski DM; Nolan TG; Norris DA; Sergeeva MV; Kirkovsky L
    Bioorg Med Chem Lett; 2009 Nov; 19(21):6047-52. PubMed ID: 19796938
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Anti-cancer and anti-hepatitis C virus NS5B polymerase activity of etodolac 1,2,4-triazoles.
    Çıkla-Süzgün P; Kaushik-Basu N; Basu A; Arora P; Talele TT; Durmaz I; Çetin-Atalay R; Küçükgüzel ŞG
    J Enzyme Inhib Med Chem; 2015; 30(5):778-85. PubMed ID: 25676325
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Synthesis and antiviral properties of novel 7-heterocyclic substituted 7-deaza-adenine nucleoside inhibitors of Hepatitis C NS5B polymerase.
    Di Francesco ME; Avolio S; Pompei M; Pesci S; Monteagudo E; Pucci V; Giuliano C; Fiore F; Rowley M; Summa V
    Bioorg Med Chem; 2012 Aug; 20(15):4801-11. PubMed ID: 22770556
    [TBL] [Abstract][Full Text] [Related]  

  • 49. In vitro characterization of GSK2485852, a novel hepatitis C virus polymerase inhibitor.
    Voitenleitner C; Crosby R; Walker J; Remlinger K; Vamathevan J; Wang A; You S; Johnson J; Woldu E; Van Horn S; Horton J; Creech K; Shotwell JB; Hong Z; Hamatake R
    Antimicrob Agents Chemother; 2013 Nov; 57(11):5216-24. PubMed ID: 23939896
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Synthesis of BILN 2061, an HCV NS3 protease inhibitor with proven antiviral effect in humans.
    Faucher AM; Bailey MD; Beaulieu PL; Brochu C; Duceppe JS; Ferland JM; Ghiro E; Gorys V; Halmos T; Kawai SH; Poirier M; Simoneau B; Tsantrizos YS; Llinàs-Brunet M
    Org Lett; 2004 Aug; 6(17):2901-4. PubMed ID: 15330643
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The design, synthesis and biological evaluations of C-6 or C-7 substituted 2-hydroxyisoquinoline-1,3-diones as inhibitors of hepatitis C virus.
    Chen YL; Tang J; Kesler MJ; Sham YY; Vince R; Geraghty RJ; Wang Z
    Bioorg Med Chem; 2012 Jan; 20(1):467-79. PubMed ID: 22100256
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Finger loop inhibitors of the HCV NS5b polymerase. Part II. Optimization of tetracyclic indole-based macrocycle leading to the discovery of TMC647055.
    Vendeville S; Lin TI; Hu L; Tahri A; McGowan D; Cummings MD; Amssoms K; Canard M; Last S; Van den Steen I; Devogelaere B; Rouan MC; Vijgen L; Berke JM; Dehertogh P; Fransen E; Cleiren E; van der Helm L; Fanning G; Van Emelen K; Nyanguile O; Simmen K; Raboisson P
    Bioorg Med Chem Lett; 2012 Jul; 22(13):4437-43. PubMed ID: 22633687
    [TBL] [Abstract][Full Text] [Related]  

  • 53. II. Novel HCV NS5B polymerase inhibitors: discovery of indole C2 acyl sulfonamides.
    Anilkumar GN; Selyutin O; Rosenblum SB; Zeng Q; Jiang Y; Chan TY; Pu H; Wang L; Bennett F; Chen KX; Lesburg CA; Duca J; Gavalas S; Huang Y; Pinto P; Sannigrahi M; Velazquez F; Venkatraman S; Vibulbhan B; Agrawal S; Ferrari E; Jiang CK; Huang HC; Shih NY; George Njoroge F; Kozlowski JA
    Bioorg Med Chem Lett; 2012 Jan; 22(1):713-7. PubMed ID: 22104146
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Synthesis and Biological Characterization of Aryl Uracil Inhibitors of Hepatitis C Virus NS5B Polymerase: Discovery of ABT-072, a trans-Stilbene Analog with Good Oral Bioavailability.
    Randolph JT; Krueger AC; Donner PL; Pratt JK; Liu D; Motter CE; Rockway TW; Tufano MD; Wagner R; Lim HB; Beyer JM; Mondal R; Panchal NS; Colletti L; Liu Y; Koev G; Kati WM; Hernandez LE; Beno DWA; Longenecker KL; Stewart KD; Dumas EO; Molla A; Maring CJ
    J Med Chem; 2018 Feb; 61(3):1153-1163. PubMed ID: 29342358
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Synthesis and anti-HCV activity of 3',4'-oxetane nucleosides.
    Chang W; Du J; Rachakonda S; Ross BS; Convers-Reignier S; Yau WT; Pons JF; Murakami E; Bao H; Steuer HM; Furman PA; Otto MJ; Sofia MJ
    Bioorg Med Chem Lett; 2010 Aug; 20(15):4539-43. PubMed ID: 20580554
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Multi-step parallel synthesis enabled optimization of benzofuran derivatives as pan-genotypic non-nucleoside inhibitors of HCV NS5B.
    Xiao D; Dai X; Liu H; He S; Shi ZC; Ludmerer SW; Li F; Nargund R; Palani A
    Bioorg Med Chem Lett; 2020 Apr; 30(7):127004. PubMed ID: 32061500
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Non-nucleoside inhibitors of HCV polymerase NS5B. Part 2: Synthesis and structure-activity relationships of benzothiazine-substituted quinolinediones.
    de Vicente J; Hendricks RT; Smith DB; Fell JB; Fischer J; Spencer SR; Stengel PJ; Mohr P; Robinson JE; Blake JF; Hilgenkamp RK; Yee C; Adjabeng G; Elworthy TR; Tracy J; Chin E; Li J; Wang B; Bamberg JT; Stephenson R; Oshiro C; Harris SF; Ghate M; Leveque V; Najera I; Le Pogam S; Rajyaguru S; Ao-Ieong G; Alexandrova L; Larrabee S; Brandl M; Briggs A; Sukhtankar S; Farrell R; Xu B
    Bioorg Med Chem Lett; 2009 Jul; 19(13):3642-6. PubMed ID: 19457662
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Discovery of Novel Hepatitis C Virus NS5B Polymerase Inhibitors by Combining Random Forest, Multiple e-Pharmacophore Modeling and Docking.
    Wei Y; Li J; Qing J; Huang M; Wu M; Gao F; Li D; Hong Z; Kong L; Huang W; Lin J
    PLoS One; 2016; 11(2):e0148181. PubMed ID: 26845440
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Inhibitors of HCV NS5B polymerase: synthesis and structure-activity relationships of unsymmetrical 1-hydroxy-4,4-dialkyl-3-oxo-3,4-dihydronaphthalene benzothiadiazine derivatives.
    Krueger AC; Madigan DL; Green BE; Hutchinson DK; Jiang WW; Kati WM; Liu Y; Maring CJ; Masse SV; McDaniel KF; Middleton TR; Mo H; Molla A; Montgomery DA; Ng TI; Kempf DJ
    Bioorg Med Chem Lett; 2007 Apr; 17(8):2289-92. PubMed ID: 17300933
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Hepatitis C NS5B polymerase inhibitors: 4,4-Dialkyl-1-hydroxy-3-oxo-3,4-dihydronaphthalene-3-yl benzothiadiazine derivatives.
    Hutchinson DK; Rosenberg T; Klein LL; Bosse TD; Larson DP; He W; Jiang WW; Kati WM; Kohlbrenner WE; Liu Y; Masse SV; Middleton T; Molla A; Montgomery DA; Beno DW; Stewart KD; Stoll VS; Kempf DJ
    Bioorg Med Chem Lett; 2008 Jul; 18(14):3887-90. PubMed ID: 18599294
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.